Alkem Foundation partners with IIT Bombay to set up India’s first CSR-led research centre for immuno-therapeutics and regenerative medicines.
Read MoreAlkem Laboratories
Alkem launches Pertuza biosimilar in India for HER2-positive breast cancer treatment
Alkem launches Pertuza biosimilar in India, offering affordable HER2-positive breast cancer treatment and strengthening its oncology portfolio.
Read More
Alkem Foundation Establishes Radiotherapy Centre in North Bihar with INR 100 Cr Investment
Alkem Foundation supports North Bihar’s largest radiotherapy centre in Muzaffarpur with ₹100 crore investment, treating 3,500–4,000 patients annually.
Read More